Clinical toxicity of daridorexant: a retrospective analysis of poison centre data
While daridorexant appears safe when taken alone, clinicians should remain vigilant in polypharmacy scenarios involving central nervous system depressants. Further studies are needed to confirm sex-related differences and refine risk stratification in overdose management.
Authors
- A. Descatha
- Ingrid Blanc-Brisset (ORCID: https://orcid.org/0000-0003-2877-0923)
- Marion Evrard
- A. Nardon
- J. Langrand
- C. Paradis
- M. Labadie
- M. Legeay
- Marc Boyé
- Katharina von Fabeck (ORCID: https://orcid.org/0000-0002-6805-027X)
- Nicolas Delcourt (ORCID: https://orcid.org/0000-0001-8136-9392)
- Marion Legeay
- Fanny Pélissier (ORCID: https://orcid.org/0000-0002-8604-4201)
- Gaël Le Roux (ORCID: https://orcid.org/0000-0002-1579-0178)
- Emmanuel Puskarczyk (ORCID: https://orcid.org/0009-0004-0936-3948)
- Patrick Nisse (ORCID: https://orcid.org/0009-0005-4852-7885)
- G. Balice
- A. Gouraud
- Weniko Caré
- Anne Garat
- Ramy Azzouz
- Céline Moulut
- Florent Battefort
- Jean-Paul Boudsocq
- Cécile Chevallier
- Coralie Bragança
- Hervé Laborde-Casterot
- Fabien Genestier
- Nicolas Simon
- Romain Torrents
- French PCC Research Group
Institutions
- Centre Hospitalier Universitaire de Lille (FR)
- Hôpital Laveran (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- Hospices Civils de Lyon (FR)
- Hôpital Fernand-Widal (FR)
- Hôpital Pellegrin (FR)
- Centre Hospitalier Universitaire d'Angers (FR)
- Hôpital Sainte-Marguerite (FR)
- Institut de Neurosciences de la Timone (FR)
- Hôpital Purpan (FR)
Publication Details
- Journal
- Clinical Toxicology
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1080/15563650.2026.2617481
- Primary Topic
- Luminescence and Fluorescent Materials
- Type
- article
- Field-Weighted Citation Impact
- 0.00